Alumis Inc. (NASDAQ:ALMS) Stake Increased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. increased its holdings in shares of Alumis Inc. (NASDAQ:ALMS – Free Report) by 4.4% ...
HC Wainwright Cuts Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target to $11.00
Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) had its price target trimmed by HC Wainwright from $15.00 to $11.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage ...